The Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, full German name "Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH", also referred to as "Bergmannsheil", formerly known as "Bergbau-Berufsgenossenschaftliche Krankenanstalten Bergmannsheil", is a tertiary teaching hospital in Bochum.

There are 707 beds in Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum.

During the past decade, Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum" #1 collaborator was "Bergmannsheil University Hospitals" with 1 trials as a collaborator, "Private Sponsor (Chantal C. Guilhemotonia-Urban)" with 1 trials as a collaborator and "Wissenschaftskommission des Universitaetsklinikums Bergmannsheil" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum" are "Euthyroid Sick Syndromes" (1 trials), "Low T3 Syndrome" (1 trials), "Non-thyroidal Illness Syndrome" (1 trials), "Seizures" (1 trials) and "Syncope" (1 trials). Many other conditions were trialed in "Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum" in a lesser frequency.

Most popular intervention types in "Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum" are "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Evalution of thyroid function" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Clinical Chemistry, Transfusion and Laboratory Medicine, Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".